Opsens Inc. OPS.TO
Set alert
As of Dec 12, 3:53 PM ET
52-week range unavailable
- Open
- 2.89
- Prev close
- 2.90
- Mkt cap
- 334.89M
- Vol
- 7.26K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.89
- High
- 2.90
- Forward P/E
- 58.00
- Beta
- 0.32
- Short ratio
- 1.91
- Inst. own
- 21.98%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.80
- 200-d avg
- 2.00
- 1y target
- 3.36
Key statistics
- Market cap
- 335.47M
- Enterprise value
- 326.57M
- Trailing P/E
- 0.00
- Forward P/E
- 58.00
- PEG ratio
- 0.00
- Price / sales
- 6.94
- Price / book
- 9.90
- EPS (TTM)
- -0.11
- Beta
- 0.32
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -25.65%
- Revenue (TTM)
- 48.35M
- Revenue growth
- 56.80%
- Free cash flow
- -12.73M
- Total cash
- 18.10M
- Total debt
- 9.21M
- Return on equity
- -36.43%
- Shares outstanding
- 115.68M
- Short % of float
- 0.00%
- 50-day average
- 2.80
- 200-day average
- 2.00
Analyst view
Consensus: buy
- Target (low)
- 2.90
- Target (mean)
- 3.36
- Target (high)
- 4.00
Next earnings
Consensus EPS estimate -0.01.
About Opsens Inc.
Opsens Inc. develops, manufactures, installs, and sells fiber optic sensors for cardiovascular interventions. The company operates in two segments, Medical and Industrial. The company provides advanced optical-based pressure guidewire (OptoWire), a guidewire used in the transcatheter aortic valve replacement procedure; and a range of miniature optical sensors to measure pressure and temperature to be used in a range of applications that can be integrated in other medical devices. It also develops, manufactures, and markets medical products; and offers OPP-GD fiber optic differential pressure sensors and the OEC fiber optic extensometer sensors. The company serves life sciences, energy, defense and aerospace, geotechnical, civil engineering, scientific laboratory, and various other markets. The company sells its products through a network of distributors and direct sales force in the United States, Japan, Canada, and internationally. Opsens Inc. was formerly known as Capital DCB inc. and changed its name to OpSens Inc. in October 2006. The company was founded in 2003 and is headquartered in Québec, Canada. As of December 12, 2023, Opsens Inc. operates as a subsidiary of Haemonetics Corporation.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- Canada
- Website
- opsens.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on OPS.TO — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| Laflamme (Louis) | Director of Issuer | Acquisition or disposition in the public market | Nov 24, 2022 | 516,000 |
| Lavigueur (Jean) | Director of Issuer | Exercise of options | Jan 23, 2022 | 265,000 |
| Milinazzo (Alan W) | Director of Issuer | Acquisition or disposition in the public market | May 11, 2022 | 65,298 |
| Villeneuve, Robin | Senior Officer of Issuer | Exercise of options | Jun 4, 2022 | 85,000 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Gagnon Securities, LLC | 2.54% | 2,922,166 | 4.76M | Jun 29, 2023 |
| Gagnon Advisors, LLC | 1.50% | 1,725,083 | 2.81M | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Baron Health Care Fund | 1.21% | 1,387,480 | 2.26M | Jun 29, 2023 |
| Royce Micro Cap Trust | 0.18% | 202,940 | 330.79K | Jun 29, 2023 |